Latest & greatest articles for mammography

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on mammography or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on mammography and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for mammography

101. Cost-effectiveness of digital mammography breast cancer screening

Cost-effectiveness of digital mammography breast cancer screening Cost-effectiveness of digital mammography breast cancer screening Cost-effectiveness of digital mammography breast cancer screening Tosteson A N, Stout N K, Fryback D G, Acharyya S, Herman B A, Hannah L G, Pisano E D Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed (...) by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary This study aimed to determine the cost-effectiveness of digital mammography screening, compared with film mammography screening, for the detection of breast cancer (BC) in women aged 40 years or more than 65 years. The study showed that screening for BC using all-digital mammography is not cost-effective, while age-targeted screening with digital mammography has the potential to be cost-effective

NHS Economic Evaluation Database.2008

102. MRI and mammography surveillance of women at increased risk for breast cancer: recommendations using an evidence-based approach

MRI and mammography surveillance of women at increased risk for breast cancer: recommendations using an evidence-based approach MRI and mammography surveillance of women at increased risk for breast cancer: recommendations using an evidence-based approach MRI and mammography surveillance of women at increased risk for breast cancer: recommendations using an evidence-based approach Granader EJ, Dwamena B, Carlos RC CRD summary The review assessed performance of MRI (magnetic (...) resonance imaging) and mammography in screening high-risk populations for breast cancer. MRI had significantly higher cancer detection rates and similar false positive rates to mammography. Weaknesses in analysis and reporting and similar performance of MRI in high risk and general populations, mean the authors conclusions on the essential role of MRI are unreliable. Authors' objectives To evaluate the performance of MRI, mammography or MRI plus mammography in screening for breast cancer in high-risk populations. Searching

DARE.2008

103. Computer aids and human second reading as interventions in screening mammography: two systematic reviews to compare effects on cancer detection and recall rate

Computer aids and human second reading as interventions in screening mammography: two systematic reviews to compare effects on cancer detection and recall rate Computer aids and human second reading as interventions in screening mammography: two systematic reviews to compare effects on cancer detection and recall rate Computer aids and human second reading as interventions in screening mammography: two systematic reviews to compare effects on cancer detection and recall rate Taylor P, Potts HW (...) is required to investigate the unexplained heterogeneity in recall rates across studies and that assumptions underlying the prompts provided in computer aid systems requires further investigation. Funding Partly supported by the NHS Breast Screening Programme. Bibliographic details Taylor P, Potts HW. Computer aids and human second reading as interventions in screening mammography: two systematic reviews to compare effects on cancer detection and recall rate. European Journal of Cancer 2008; 44(6): 798

DARE.2008

105. Cost-effectiveness of digital mammography breast cancer screening.

Cost-effectiveness of digital mammography breast cancer screening. BACKGROUND: The DMIST (Digital Mammography Imaging Screening Trial) reported improved breast cancer detection with digital mammography compared with film mammography in selected population subgroups, but it did not assess the economic value of digital relative to film mammography screening. OBJECTIVE: To evaluate the cost-effectiveness of digital mammography screening for breast cancer. DESIGN: Validated, discrete-event (...) simulation model. DATA SOURCES: Data from DMIST and publicly available U.S. data. TARGET POPULATION: U.S. women age 40 years or older. TIME HORIZON: Lifetime. PERSPECTIVE: Societal and Medicare. INTERVENTION: All-film mammography screening; all-digital mammography screening; and targeted digital mammography screening, which is age-targeted digital mammography (for women <50 years of age) and age- and density-targeted digital mammography (for women <50 years of age or women > or =50 years of age

Annals of Internal Medicine2008 Full Text: Link to full Text with Trip Pro

106. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer.

Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. 18477782 2008 05 14 2008 05 20 2016 12 15 1538-3598 299 18 2008 May 14 JAMA JAMA Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. 2151-63 10.1001/jama.299.18.2151 Screening ultrasound may depict small, node-negative breast cancers not seen on mammography. To compare the diagnostic yield, defined as the proportion (...) of women with positive screen test results and positive reference standard, and performance of screening with ultrasound plus mammography vs mammography alone in women at elevated risk of breast cancer. From April 2004 to February 2006, 2809 women, with at least heterogeneously dense breast tissue in at least 1 quadrant, were recruited from 21 sites to undergo mammographic and physician-performed ultrasonographic examinations in randomized order by a radiologist masked to the other examination results

JAMA2008 Full Text: Link to full Text with Trip Pro

107. Single reading with computer-aided detection for screening mammography.

Single reading with computer-aided detection for screening mammography. 18832239 2008 10 16 2008 10 23 2016 11 24 1533-4406 359 16 2008 Oct 16 The New England journal of medicine N. Engl. J. Med. Single reading with computer-aided detection for screening mammography. 1675-84 10.1056/NEJMoa0803545 The sensitivity of screening mammography for the detection of small breast cancers is higher when the mammogram is read by two readers rather than by a single reader. We conducted a trial to determine (...) whether the performance of a single reader using a computer-aided detection system would match the performance achieved by two readers. The trial was designed as an equivalence trial, with matched-pair comparisons between the cancer-detection rates achieved by single reading with computer-aided detection and those achieved by double reading. We randomly assigned 31,057 women undergoing routine screening by film mammography at three centers in England to double reading, single reading with computer

NEJM2008

108. Influence of computer-aided detection on performance of screening mammography.

Influence of computer-aided detection on performance of screening mammography. BACKGROUND: Computer-aided detection identifies suspicious findings on mammograms to assist radiologists. Since the Food and Drug Administration approved the technology in 1998, it has been disseminated into practice, but its effect on the accuracy of interpretation is unclear. METHODS: We determined the association between the use of computer-aided detection at mammography facilities and the performance of screening (...) mammography from 1998 through 2002 at 43 facilities in three states. We had complete data for 222,135 women (a total of 429,345 mammograms), including 2351 women who received a diagnosis of breast cancer within 1 year after screening. We calculated the specificity, sensitivity, and positive predictive value of screening mammography with and without computer-aided detection, as well as the rates of biopsy and breast-cancer detection and the overall accuracy, measured as the area under

NEJM2007 Full Text: Link to full Text with Trip Pro

109. Screening mammography for women 40 to 49 years of age: a clinical practice guideline from the American College of Physicians.

Screening mammography for women 40 to 49 years of age: a clinical practice guideline from the American College of Physicians. Breast cancer is one of the most common causes of death for women in their 40s in the United States. Individualized risk assessment plays an important role when making decisions about screening mammography, especially for women 49 years of age or younger. The purpose of this guideline is to present the available evidence for screening mammography in women 40 to 49 years (...) of age and to increase clinicians' understanding of the benefits and risks of screening mammography.

Annals of Internal Medicine2007

111. A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer

A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young (...) to be reliable but there is a possibility of publication bias. Authors' objectives To determine the value of adding magnetic resonance imaging (MRI) to mammography with or without ultrasound and clinical breast examination (CBE) for screening young women at high risk of breast cancer. Searching MEDLINE, PREMEDLINE, EMBASE, the Cochrane Library and websites of health technology assessment agencies were searched from inception to March 2007; the search terms were reported. Only English language publications

DARE.2007

112. Routine screening mammography in women older than 74 years: a review of the available data

Routine screening mammography in women older than 74 years: a review of the available data Routine screening mammography in women older than 74 years: a review of the available data Routine screening mammography in women older than 74 years: a review of the available data Galit W, Green M S, Lital K B CRD summary This review found that screening mammography in women aged over 75 years could reduce breast cancer mortality. These conclusions should be interpreted with extreme caution given (...) for additional relevant studies. Study selection Study designs of evaluations included in the review Initially it was intended to limit the review to randomised controlled trials, but as none were found the criteria were broadened to include observational studies. The included studies comprised retrospective cohort studies and one case-control study. Specific interventions included in the review Studies that assessed screening mammography were eligible for inclusion. In most, but not all of the included

DARE.2007

113. Cost-effectiveness analysis of a quality-controlled mammography screening program from the Swiss statutory health-care perspective: quantitative assessment of the most influential factors

Cost-effectiveness analysis of a quality-controlled mammography screening program from the Swiss statutory health-care perspective: quantitative assessment of the most influential factors Cost-effectiveness analysis of a quality-controlled mammography screening program from the Swiss statutory health-care perspective: quantitative assessment of the most influential factors Cost-effectiveness analysis of a quality-controlled mammography screening program from the Swiss statutory health-care (...) -effectiveness of a mammography screening programme (MSP) aimed at reducing breast cancer, compared with an established opportunistic screening programme, in Switzerland. The authors concluded that the MSP was a cost-effective strategy, but it seems that there is high uncertainty around the findings. Overall, the study was carried out satisfactorily, with good reporting of the methods and results. Type of economic evaluation Cost-effectiveness analysis Study objective The primary objective of the study

NHS Economic Evaluation Database.2007

114. Cost effectiveness of mammography screening for Chinese women

Cost effectiveness of mammography screening for Chinese women Cost effectiveness of mammography screening for Chinese women Cost effectiveness of mammography screening for Chinese women Wong I O, Kuntz K M, Cowling B J, Lam C L, Leung G M Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment (...) on the reliability of the study and the conclusions drawn. CRD summary The study objective was to determine the cost-effectiveness of biennal screening with mammography, compared with no screening, for the detection of breast cancer in 40-year-old Chinese women. The authors concluded that when using epidemiological data for Chinese women, biennal screening was not a cost-effective alternative to no screening, given the low incidence of disease in this specific ethnic group. The study methodology appears

NHS Economic Evaluation Database.2007

115. Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis

Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis Medical Advisory Secretariat Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation (...) of the quality of this assessment has been made for the HTA database. Citation Medical Advisory Secretariat. Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis. Toronto: Medical Advisory Secretariat (MAS). Volume 7(1). 2007 Authors' objectives The aim of this review was to determine the effectiveness of screening mammography in women aged 40 to 49 years at average risk for breast cancer. The following questions were asked: Does screening

Health Technology Assessment (HTA) Database.2007

116. Does utilization of screening mammography explain racial and ethnic differences in breast cancer?

Does utilization of screening mammography explain racial and ethnic differences in breast cancer? BACKGROUND: Reasons for persistent differences in breast cancer mortality rates among various racial and ethnic groups have been difficult to ascertain. OBJECTIVE: To determine reasons for disparities in breast cancer outcomes across racial and ethnic groups. DESIGN: Prospective cohort. SETTING: The authors pooled data from 7 mammography registries that participate in the National Cancer Institute (...) -funded Breast Cancer Surveillance Consortium. Cancer diagnoses were ascertained through linkage with pathology databases; Surveillance, Epidemiology, and End Results programs; and state tumor registries. PARTICIPANTS: 1,010,515 women 40 years of age and older who had at least 1 mammogram between 1996 and 2002; 17,558 of these women had diagnosed breast cancer. MEASUREMENTS: Patterns of mammography and the probability of inadequate mammography screening were examined. The authors evaluated whether

Annals of Internal Medicine2006

117. Full-field digital mammography

Full-field digital mammography Full-field digital mammography Full-field digital mammography BlueCross BlueShield Association Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. The BlueCross BlueShield Association Technology Evaluation Center website ( ) includes the most recent 3 years of TEC Assessments. To request older reports, please use the “contact us” feature (...) on the website. Citation BlueCross BlueShield Association. Full-field digital mammography. Chicago: BlueCross BlueShield Association (BCBS). TEC Assessment 20(16). 2006 Authors' objectives This assessment aims to update the July 2002 Assessment on full-field digital mammography and to compare cancer detection, recall, and biopsy rates for full-field digital mammography versus screen-film mammography. Authors' conclusions There is strong evidence showing that digital mammography is as accurate as film

Health Technology Assessment (HTA) Database.2006

118. Retrospective cost-effectiveness analysis of screening mammography

Retrospective cost-effectiveness analysis of screening mammography Retrospective cost-effectiveness analysis of screening mammography Retrospective cost-effectiveness analysis of screening mammography Stout N K, Rosenberg M A, Trentham-Dietz A, Smith M A, Robinson S M, Fryback D G Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed (...) by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Several strategies for screening mammography and the subsequent treatment of breast cancer (BC) were examined. The primary strategy was screening mammography as implemented in the USA from 1990 to 2000. This consisted of screening all women aged 40 years or older annually or biennially. Sixty-four alternative mammography screening scenarios were considered, each with a particular fixed screening

NHS Economic Evaluation Database.2006

119. Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer

Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer Griebsch I, Brown J, Boggis C, Dixon (...) drawn. Health technology The study compared three screening strategies aimed at women with a high risk of breast cancer. The strategies compared were mammography (XRM) alone, contrast-enhanced magnetic resonance imaging (CE MRI) alone, and a combination of XRM and CE MRI. CE MRI was conducted using a specific protocol with gadopentetate dimeglumine (Magnevists, Schering Healthcare) as the contrast medium (bolus intravenous injection of 0.2 mmol/kg body weight). Type of intervention Screening

NHS Economic Evaluation Database.2006

120. Digital mammography: an update

Digital mammography: an update Digital mammography: an update Digital mammography: an update Hailey D Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Hailey D. Digital mammography: an update. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). Issues in Emerging Health Technologies Issue 91. 2006 Authors' objectives (...) This bulletin provides an update of the literature published since an assessment was done by the Canadian Coordinating Office for Health Technology Assessment (CCOHTA), in 2002 (Ho C, et al. Digital mammography versus filmscreen mammography: technical, clinical and economic assessments [Technology report no. 30]). Authors' conclusions Digital mammography can improve breast-image quality and storage through the digital capture of x-ray images. Large comparative studies indicate that the overall accuracy

Health Technology Assessment (HTA) Database.2006